company background image
1FRE logo

Fresenius SE KGaA BIT:1FRE Stock Report

Last Price

€33.89

Market Cap

€19.1b

7D

1.7%

1Y

22.5%

Updated

03 Oct, 2024

Data

Company Financials +

1FRE Stock Overview

A health care company, provides products and services for chronically ill patients.

1FRE fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance4/6
Financial Health3/6
Dividends0/6

Fresenius SE & Co. KGaA Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Fresenius SE KGaA
Historical stock prices
Current Share Price€33.89
52 Week High€34.80
52 Week Low€23.93
Beta1.07
11 Month Change1.59%
3 Month Change16.78%
1 Year Change22.48%
33 Year Change-14.42%
5 Year Change-17.38%
Change since IPO-48.96%

Recent News & Updates

Recent updates

Shareholder Returns

1FREIT HealthcareIT Market
7D1.7%-1.7%-3.1%
1Y22.5%-3.6%17.9%

Return vs Industry: 1FRE exceeded the Italian Healthcare industry which returned -6.3% over the past year.

Return vs Market: 1FRE exceeded the Italian Market which returned 19.8% over the past year.

Price Volatility

Is 1FRE's price volatile compared to industry and market?
1FRE volatility
1FRE Average Weekly Movement2.9%
Healthcare Industry Average Movement3.8%
Market Average Movement4.1%
10% most volatile stocks in IT Market6.7%
10% least volatile stocks in IT Market2.5%

Stable Share Price: 1FRE has not had significant price volatility in the past 3 months compared to the Italian market.

Volatility Over Time: 1FRE's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1912175,771Michael Senwww.fresenius.com

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.

Fresenius SE & Co. KGaA Fundamentals Summary

How do Fresenius SE KGaA's earnings and revenue compare to its market cap?
1FRE fundamental statistics
Market cap€19.13b
Earnings (TTM)€721.00m
Revenue (TTM)€22.63b

26.5x

P/E Ratio

0.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1FRE income statement (TTM)
Revenue€22.63b
Cost of Revenue€17.41b
Gross Profit€5.23b
Other Expenses€4.51b
Earnings€721.00m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Nov 06, 2024

Earnings per share (EPS)1.28
Gross Margin23.09%
Net Profit Margin3.19%
Debt/Equity Ratio61.2%

How did 1FRE perform over the long term?

See historical performance and comparison